DAY 1

12:00 - 13:00 WEBINAR OPEN FOR LOGIN  
OPENING: WELCOME TO IHEM 2021 SPEAKER
13:00 - 13:20OpeningH. Gisslinger
13:20 - 13:40Transplantation - Ultima ratio?N. Kröger
SESSION1: MPN AS A JOURNEY SPEAKER
CHAIRS: R. Kralovics & M. Hrubiško  
13:40 - 14:10Clonal evolutionJ. Scandura
14:10 - 14:40Risk stratificationA. Vannucchi
14:40 - 15:00COFFEE BREAK
SESSION2: INTERFERON IN PV SPEAKER
CHAIRS: D. Wolf & M. Griesshammer  
15:10 - 15:35Interferon in PV – How early is early?T. Barbui
15:35 - 16:00Interferon in 1st line – What can we expect? D. Wolf
16:00 - 16:25PV - Aiming for improvement in survivalR. Silver
16:25 - 16:45Positions - Treatment holiday vs low dose maintenanceJJ. Kiladjian
H. Gisslinger
16:45 - 17:05Discussion - Treatment holiday vs low dose maintenanceJJ. Kiladjian
H. Gisslinger
17:05 - 17:30Insights - Interferon in COVID-19W. Haseltine

DAY 2

9:00 - 10:00 WEBINAR OPEN FOR LOGIN  
SESSION3: HOW I TREAT A PV PATIENT SPEAKER
CHAIRS: A. Hatalová & C. Lykkegaard Andersen  
10:00 - 10:25The challenge of pregnancyM. Griesshammer
10:25 - 10:50The challenge of switchingV. Buxhofer-Ausch
10:50 - 11:15Patient Case presentation – Czech ExperienceM. Doubek
11:15 - 11:35COFFEE BREAK
SESSION4: ET IN THEORY AND PRACTICE SPEAKER
CHAIRS: R. Kušec & C. Harrison  
11:35 - 12:00Clonal evolutionM. Kvasnicka
12:00 - 12:25Risk stratificationS. Koschmieder
12:25 - 13:00COFFEE BREAK
SESSION5: TREATMENT CONCEPTS IN MPN AND BEYOND SPEAKER
CHAIRS: G. Birgegård & S. Koschmieder  
13:00 - 13:25Combination therapyH. Hasselbalch
13:25 - 13:50Interferon in other indicationsC. Harrison
13:50 - 14:15Achieving remission in CMLA. Burchert
14:15 - 14:40Treating CMML and MDS in 2021U. Platzbecker
14:40 - 15:05Development of individualized treatment options for MPNR. Kralovics
15:05 - 15:30From IHEM 2021 to IHEM 2022H. Gisslinger